FIM
LKFT

Freedom Investment Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Freedom Investment Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,621
Closed -$1.3M – 848
2021
Q4 		$1.3M Buy
23,621
+1,426
+6% +$74.4K 0.1% 274
2021
Q3 		$1.17M Buy
22,195
+4,310
+24% +$256K 0.09% 291
2021
Q2 		$1.23M Sell
17,885
-2,885
-14% -$220K 0.09% 274
2021
Q1 		$1.6M Buy
20,770
+1,334
+7% +$123K 0.12% 192
2020
Q4 		$1.92M Sell
19,436
-1,598
-8% -$195K 0.21% 107
2020
Q3 		$2.98M Sell
21,034
-3,855
-15% -$643K 0.32% 67
2020
Q2 		$4.91M Sell
24,889
-4,348
-15% -$901K 0.53% 34
2020
Q1 		$7.22M Buy
29,237
+5,618
+24% +$1.21M 0.64% 25
2019
Q4 		$4.88M Sell
23,619
-540
-2% -$99.8K 0.43% 49
2019
Q3 		$3.69M Sell
24,159
-412
-2% -$67.5K 0.32% 57
2019
Q2 		$3.17M Sell
24,571
-1,043
-4% -$124K 0.27% 73
2019
Q1 		$3.02M Buy
25,614
+4,801
+23% +$484K 0.24% 82
2018
Q4 		$1.91M Sell
20,813
-394
-2% -$39.9K 0.15% 128
2018
Q3 		$2.09M Buy
21,207
+6,289
+42% +$664K 0.13% 151
2018
Q2 		$1.38M Buy
14,918
+2,574
+21% +$250K 0.08% 260
2018
Q1 		$1.23M Buy
12,344
+1,001
+9% +$108K 0.06% 308
2017
Q4 		$1.06M Sell
11,343
-849
-7% -$80.3K 0.05% 343
2017
Q3 		$1.24M Buy
12,192
+1,846
+18% +$161K 0.07% 267
2017
Q2 		$792K Buy
10,346
+2,314
+29% +$195K 0.05% 401
2017
Q1 		$692K Buy
8,032
+3,297
+70% +$237K 0.04% 421
2016
Q4 		$304K Buy
+4,735
New +$291K 0.02% 692

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Freedom Investment Management's LKFT Position: Q1 2022 in Review

Freedom Investment Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2022, closing a stake of 23,621 shares — an estimated $1.3M sold.

Freedom Investment Management first reported a position in LKFT in Q4 2016 and held it in 21 quarters. The position peaked at $7.22M in Q1 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2022.

  • Freedom Investment Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Freedom Investment Management sold 23,621 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2022, an estimated $1.3M.
  • Freedom Investment Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 21 quarters.
  • Freedom Investment Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $7.22M in Q1 2020.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.